Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2015 · 10-Q
Revenue—
Net Income$73.00K$73.00K+10.6% vs Q2 2014 EPS Diluted$0.00$0.00— vs Q2 2014 Operating Income$72,000+10.8% Operating Cash Flowderived$90,000+13.9%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 12, 2015 · 43 d after period end